Cargando…

Bartonella henselae-associated recurrent, bilateral segmental periphlebitis

PURPOSE: To describe a patient with atypical Bartonella henselae (B. henselae)-associated ocular inflammation that manifested with recurrent, bilateral segmental periphlebitis. OBSERVATIONS: A 32-year-old White man presented with multiple paracentral scotomata in each eye. Examination revealed mild...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Caleb C., Ng, Joshua, McDonald, H. Richard, Cunningham, Emmett T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935419/
https://www.ncbi.nlm.nih.gov/pubmed/35321248
http://dx.doi.org/10.1016/j.ajoc.2022.101475
_version_ 1784672038956302336
author Ng, Caleb C.
Ng, Joshua
McDonald, H. Richard
Cunningham, Emmett T.
author_facet Ng, Caleb C.
Ng, Joshua
McDonald, H. Richard
Cunningham, Emmett T.
author_sort Ng, Caleb C.
collection PubMed
description PURPOSE: To describe a patient with atypical Bartonella henselae (B. henselae)-associated ocular inflammation that manifested with recurrent, bilateral segmental periphlebitis. OBSERVATIONS: A 32-year-old White man presented with multiple paracentral scotomata in each eye. Examination revealed mild vitreous cell, segmental sheathing of the retinal veins, and inflammation of the paravenous retina in each eye. Multimodal imaging, including optical coherence tomography as well as widefield fundus autofluorescence, fluorescein angiography, and indocyanine green angiography, was consistent with bilateral, segmental retinal periphlebitis with paravenous inflammation and retinochoroidal scarring. Serology showed elevated B. henselae antibody titers, but was otherwise unrevealing, and the patient was diagnosed with presumed B. henselae-associated ocular inflammation. Treatment with systemic doxycycline (100 mg PO BID) for four weeks improved the patient's symptoms and posterior uveitis. However, after an asymptomatic period of nearly one year, his bilateral pericentral scotomata recurred and posterior segment examination confirmed new foci of retinal periphlebitis in each eye. Re-treatment with doxycycline (100 mg PO BID) for four weeks again yielded improvement, but one month after completing his antibiotic course, his visual symptoms recurred, and we observed additional areas of periphlebitis and paravenous retinitis with associated branch retinal vein occlusions in each eye. This time a dual antibiotic regimen of doxycycline (100 mg PO BID) and rifampin (300 mg PO BID) was administered for three months, with improvement. Over the next eight years, the patient experienced no further disease relapse, and the previous sites of retinal periphlebitis eventually developed perivenous fibrosis with paravenous retinochoroidal scarring. CONCLUSION: Rarely, patients with B. henselae-associated ocular inflammation develop segmental retinal periphlebitis with or without retinal vein occlusion. This form of ocular bartonellosis can recur, requiring multiple courses of antimicrobial therapy.
format Online
Article
Text
id pubmed-8935419
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-89354192022-03-22 Bartonella henselae-associated recurrent, bilateral segmental periphlebitis Ng, Caleb C. Ng, Joshua McDonald, H. Richard Cunningham, Emmett T. Am J Ophthalmol Case Rep Case Report PURPOSE: To describe a patient with atypical Bartonella henselae (B. henselae)-associated ocular inflammation that manifested with recurrent, bilateral segmental periphlebitis. OBSERVATIONS: A 32-year-old White man presented with multiple paracentral scotomata in each eye. Examination revealed mild vitreous cell, segmental sheathing of the retinal veins, and inflammation of the paravenous retina in each eye. Multimodal imaging, including optical coherence tomography as well as widefield fundus autofluorescence, fluorescein angiography, and indocyanine green angiography, was consistent with bilateral, segmental retinal periphlebitis with paravenous inflammation and retinochoroidal scarring. Serology showed elevated B. henselae antibody titers, but was otherwise unrevealing, and the patient was diagnosed with presumed B. henselae-associated ocular inflammation. Treatment with systemic doxycycline (100 mg PO BID) for four weeks improved the patient's symptoms and posterior uveitis. However, after an asymptomatic period of nearly one year, his bilateral pericentral scotomata recurred and posterior segment examination confirmed new foci of retinal periphlebitis in each eye. Re-treatment with doxycycline (100 mg PO BID) for four weeks again yielded improvement, but one month after completing his antibiotic course, his visual symptoms recurred, and we observed additional areas of periphlebitis and paravenous retinitis with associated branch retinal vein occlusions in each eye. This time a dual antibiotic regimen of doxycycline (100 mg PO BID) and rifampin (300 mg PO BID) was administered for three months, with improvement. Over the next eight years, the patient experienced no further disease relapse, and the previous sites of retinal periphlebitis eventually developed perivenous fibrosis with paravenous retinochoroidal scarring. CONCLUSION: Rarely, patients with B. henselae-associated ocular inflammation develop segmental retinal periphlebitis with or without retinal vein occlusion. This form of ocular bartonellosis can recur, requiring multiple courses of antimicrobial therapy. Elsevier 2022-03-14 /pmc/articles/PMC8935419/ /pubmed/35321248 http://dx.doi.org/10.1016/j.ajoc.2022.101475 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Ng, Caleb C.
Ng, Joshua
McDonald, H. Richard
Cunningham, Emmett T.
Bartonella henselae-associated recurrent, bilateral segmental periphlebitis
title Bartonella henselae-associated recurrent, bilateral segmental periphlebitis
title_full Bartonella henselae-associated recurrent, bilateral segmental periphlebitis
title_fullStr Bartonella henselae-associated recurrent, bilateral segmental periphlebitis
title_full_unstemmed Bartonella henselae-associated recurrent, bilateral segmental periphlebitis
title_short Bartonella henselae-associated recurrent, bilateral segmental periphlebitis
title_sort bartonella henselae-associated recurrent, bilateral segmental periphlebitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935419/
https://www.ncbi.nlm.nih.gov/pubmed/35321248
http://dx.doi.org/10.1016/j.ajoc.2022.101475
work_keys_str_mv AT ngcalebc bartonellahenselaeassociatedrecurrentbilateralsegmentalperiphlebitis
AT ngjoshua bartonellahenselaeassociatedrecurrentbilateralsegmentalperiphlebitis
AT mcdonaldhrichard bartonellahenselaeassociatedrecurrentbilateralsegmentalperiphlebitis
AT cunninghamemmettt bartonellahenselaeassociatedrecurrentbilateralsegmentalperiphlebitis